India, Aug. 5 -- Terns Pharmaceuticals, Inc. (TERN) released Loss for second quarter of -$24.09 million
The company's bottom line came in at -$24.09 million, or -$0.26 per share. This compares with -$22.73 million, or -$0.31 per share, last year.
Terns Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: -$24.09 Mln. vs. -$22.73 Mln. last year.-EPS: -$0.26 vs. -$0.31 last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....